Companies/US/IPHA

Innate Pharma SA

Ownership & governance

No ownership or governance data for this issuer yet.

Institutional (13F)

Loading Form 13F holders…

Fund membership

Loading fund baskets…

Street consensus

Consensus noneMean target 6.67Range 4–9Analysts 3
4Mean 6.679
  • Buy 3

Broker actions37

FirmActionToTargetDate
BTIGReiteratedBuy92026-09-17
BTIGMaintainedBuy92026-08-12
HC Wainwright & Co.MaintainedBuy72026-08-10
HC Wainwright & Co.ReiteratedBuy52026-04-07
HC Wainwright & Co.UpgradeBuy52025-10-29
BTIGReiteratedBuy82025-10-29
Leerink PartnersDowngradeMarket Perform22025-09-18
HC Wainwright & Co.DowngradeNeutral—2025-09-18
HC Wainwright & Co.ReiteratedBuy112025-04-24
HC Wainwright & Co.ReiteratedBuy11.52025-03-28
HC Wainwright & Co.ReiteratedBuy11.52025-02-06
HC Wainwright & Co.ReiteratedBuy11.52025-01-17

Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.

Peers